Our mission is to find the real causes and solutions of diseases through AI.
On July 13, 2022, Voxelcloud's "Computer-Assisted Diagnosis Software for Diabetic Retinopathy Based on Fundus Images " was approved for NMPA Class III.
The company is committed to discovering and exploring the mechanisms of life and health, empowering medicine with inspiration, care, and evidence, summarizing the laws of life balance using artificial intelligence technology, and providing the public with healing information on people and the environment.
Ophthalmology AI Solution
VoxelCloud Retina
Radiology AI Solution
VoxelCloud Thorax
Dermatology AI Solution
VoxelCloud DermX
VoxelCloud DermS
News
Learn about the latest news about VoxelCloud.
Read More
2017-10-25
This Tencent-backed startup wants to use AI to solve disparities in China’s healthcare
2017-10-03
VoxelCloud Raises $15M Series A+ Led by Tencent to Expand Its AI Medical Products Beyond Hospitals
2017-10-01
Tencent leads $15m Series A+ in VoxelCloud
To provide you with personalised healing information, please contact us.